SCN9A and paroxysmal extreme pain disorder: By contrast, gain-of-function mutations of NaV1.7 result in hyperexcitability of sensory neurons and underlie severe neuropathic pain conditions such as primary erythromelalgia (PE) and paroxysmal extreme pain disorder (PEPD) [14].